8-K: DSS Inc. Secures $500K Loan from Alset Inc.

DSS, Inc. has entered into a securities purchase agreement with Alset Inc. for a $500,000 convertible note and warrants, subject to stockholder approval.

Summary

• DSS, Inc. (the Company) entered into a Securities Purchase Agreement (SPA) with Alset Inc. on September 15, 2026.
• Alset Inc. loaned the Company $500,000 in exchange for a convertible promissory note and warrants to purchase 8,000,000 shares of common stock.
• The convertible note accrues simple interest at 3% per annum and is payable on demand.
• Alset Inc. can convert the principal and interest into common stock at $0.50 per share.
• The warrants allow purchase of up to 8,000,000 shares at an exercise price of $0.55 per share, expiring on their fifth anniversary.
• Both the note conversion and warrant exercise require stockholder approval.
• Alset Inc. and DSS, Inc. are related parties due to common control by DSS's Chairman, Chan Heng Fai, who also chairs Alset Inc.
• Several directors and officers of Alset Inc. also hold positions at DSS, Inc.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the related party nature of the transaction and the need for stockholder approval, indicating potential governance concerns and dilution risk.

Positives

• Secured $500,000 in immediate funding through the loan.
• The convertible note and warrants provide potential future capital infusion if converted/exercised.
• The transaction was approved by the Company's Board of Directors and Audit Committee.

Negatives

• The transaction involves related parties, raising potential governance concerns.
• Stockholder approval is required for note conversion and warrant exercise, creating uncertainty.
• Potential for significant dilution of existing shareholders if the note is converted or warrants are exercised.
• The convertible note is payable on demand, which could create liquidity pressure if called.
• The exercise price of the warrants ($0.55) is higher than the conversion price of the note ($0.50).

Risks

• Risk of significant shareholder dilution if the note is converted or warrants are exercised.
• Potential conflicts of interest due to the related-party nature of the transaction.
• Uncertainty surrounding the required stockholder approval for conversion and exercise.
• Liquidity risk if Alset Inc. demands repayment of the note.
• The company's stock price may need to exceed $0.55 for warrant holders to exercise, potentially impacting future capital raising efforts.

Future Outlook

The future outlook is contingent on stockholder approval for the conversion of the note and exercise of warrants. If approved, it could lead to significant dilution but also provide additional capital. The note is payable on demand, introducing potential short-term liquidity considerations.

Management Comments

• The transaction documents were approved by the Company's Board of Directors and Audit Committee.

Industry Context

StockSavvy.ai notes that related-party financing, especially involving convertible instruments and warrants, is a common, albeit scrutinized, method for companies to secure capital. The requirement for stockholder approval highlights the importance of corporate governance and shareholder rights in such transactions.

Corporate Governance

Related Party Transactions

• DSS, Inc. entered into a securities purchase agreement with Alset Inc., a related party.
• Alset Inc. loaned DSS, Inc. $500,000 in exchange for a convertible promissory note and warrants.
• The company and Alset Inc. are under common control by DSS's Chairman, Chan Heng Fai.
• Several individuals hold directorships and officer positions in both companies.

Stakeholder Impact

• Shareholders: Potential for significant dilution of ownership and voting power if the note is converted or warrants are exercised. The terms of the agreement require stockholder approval.
• Creditors: The $500,000 loan may improve short-term liquidity, but the demand-payable nature of the note could pose future risks.
• Management: The transaction was approved by the Board and Audit Committee, indicating internal oversight.

Next Steps

• Obtain stockholder approval for the conversion of the convertible promissory note and the exercise of warrants.
• Potential conversion of the note by Alset Inc. into common stock.
• Potential exercise of warrants by Alset Inc. to purchase common stock.

Key Dates

Recommendation

The filing indicates a need for immediate funding, but the terms involve a related party and require stockholder approval, introducing significant uncertainty and potential dilution. While the funding is positive, the governance concerns and potential for dilution warrant a cautious 'hold' stance until shareholder approval is obtained and the impact is clearer.

Keywords

convertible note, warrants, securities purchase agreement, related party transaction, stockholder approval, capital raise, dilution